Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0150
0.00 (0.00%)
At close: Nov 9, 2026
Vincerx Pharma Market Cap
Vincerx Pharma has a market cap or net worth of $78.51 thousand as of November 9, 2026. It is the 51,292nd most valuable company in the world and the 7,307th biggest in the United States. Its market cap has increased by 194.12% in one year.
Market Cap
78.51K
Enterprise Value
-4.36M
Revenue
n/a
Global Rank
Country Rank
#7,307 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 27, 2020, Vincerx Pharma's market cap has decreased from 22.32M to 78.51K, a decrease of -99.65%. That is a compound annual growth rate of -58.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 78.51K | 20.00% |
| Dec 31, 2025 | 65.43K | -99.26% |
| Dec 31, 2024 | 8.84M | -64.95% |
| Dec 29, 2023 | 25.23M | 16.73% |
| Dec 30, 2022 | 21.61M | -89.91% |
| Dec 31, 2021 | 214.20M | -26.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sorrento Therapeutics | 163.11K |
| Sigyn Therapeutics | 147.84K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| PaxMedica | 88.39K |
| ProtoKinetix | 82.33K |
| U.S. Stem Cell | 66.15K |
| Affymax | 59.59K |